Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study

A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer

(2010) Alejandra T. Perez et al.   BREAST CANCER RESEARCH AND TREATMENT

Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells

(2010) Sylvia Fong et al.   CANCER BIOLOGY & THERAPY

Development and validation of a sensitive assay for the quantification of imatinib using LC/LC-MS/MS in human whole blood and cell culture

(2009) Jelena Klawitter et al.   BIOMEDICAL CHROMATOGRAPHY

Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study

(2009) J Klawitter et al.   BRITISH JOURNAL OF CANCER

Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells

(2009) Jelena Klawitter et al.   BRITISH JOURNAL OF PHARMACOLOGY

Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells

(2009) D. J. Kominsky et al.   CLINICAL CANCER RESEARCH

Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic

(2008) Andy T.Y. Lau et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3

(2008) Zhi-Jun Dai et al.   WORLD JOURNAL OF GASTROENTEROLOGY